Embecta Corp. (EMBC)
USD 12.27
(2.12%)
USD 12.27
(2.12%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 528.4 Million USD | 29.4% |
| 2022 | 406.4 Million USD | 31.95% |
| 2021 | 308 Million USD | 11.55% |
| 2020 | 276.1 Million USD | -2.78% |
| 2019 | 284 Million USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q3 | 106.2 Million USD | 19.4% |
| 2024 Q1 | 140.4 Million USD | -8.53% |
| 2024 Q2 | 112.4 Million USD | -19.94% |
| 2023 Q4 | 153.5 Million USD | 11.07% |
| 2023 FY | 525.9 Million USD | 29.4% |
| 2023 Q3 | 138.2 Million USD | 2.98% |
| 2023 Q2 | 134.2 Million USD | 34.2% |
| 2023 Q1 | 100 Million USD | -17.36% |
| 2022 Q1 | 87.3 Million USD | -5.72% |
| 2022 FY | 406.4 Million USD | 31.95% |
| 2022 Q4 | 121 Million USD | 14.37% |
| 2022 Q3 | 105.8 Million USD | 14.63% |
| 2022 Q2 | 92.3 Million USD | 5.73% |
| 2021 Q1 | 67.2 Million USD | 0.0% |
| 2021 Q4 | 92.6 Million USD | 18.26% |
| 2021 Q3 | 78.3 Million USD | 12.02% |
| 2021 FY | 308 Million USD | 11.55% |
| 2021 Q2 | 69.9 Million USD | 4.02% |
| 2020 FY | 276.1 Million USD | -2.78% |
| 2019 FY | 284 Million USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Bright Green Corporation | 8.25 Million USD | -6302.62% |
| Alpha Teknova, Inc. | 45.85 Million USD | -1052.227% |
| ANI Pharmaceuticals, Inc. | 195.98 Million USD | -169.615% |
| Aquestive Therapeutics, Inc. | 44.85 Million USD | -1078.044% |
| Collegium Pharmaceutical, Inc. | 159.2 Million USD | -231.893% |
| Cosmos Health Inc. | 26.18 Million USD | -1918.274% |
| Journey Medical Corporation | 54.59 Million USD | -867.872% |
| Esperion Therapeutics, Inc. | 271.89 Million USD | -94.338% |
| Dynavax Technologies Corporation | 219.14 Million USD | -141.119% |
| Intra-Cellular Therapies, Inc. | 590 Million USD | 10.442% |
| Pacira BioSciences, Inc. | 326.37 Million USD | -61.899% |
| PainReform Ltd. | 9.58 Million USD | -5413.356% |
| Sunshine Biopharma, Inc. | 13.12 Million USD | -3926.067% |
| Sunshine Biopharma, Inc. | 13.12 Million USD | -3926.067% |
| SCYNEXIS, Inc. | 51.84 Million USD | -919.133% |
| Safety Shot Inc | 12.1 Million USD | -4263.446% |
| China SXT Pharmaceuticals, Inc. | 3.06 Million USD | -17116.28% |
| Procaps Group, S.A. | 199.47 Million USD | -164.893% |
| Theratechnologies Inc. | 72.75 Million USD | -626.263% |
| Harrow Health, Inc. | 89.97 Million USD | -487.287% |
| Sonoma Pharmaceuticals, Inc. | 9.44 Million USD | -5493.902% |
| Biofrontera Inc. | 39.95 Million USD | -1222.355% |
| DURECT Corporation | 43.71 Million USD | -1108.738% |
| Supernus Pharmaceuticals, Inc. | 529.01 Million USD | 0.115% |
| Cronos Group Inc. | 96.7 Million USD | -446.381% |
| OptiNose, Inc. | 85.1 Million USD | -520.902% |
| Ironwood Pharmaceuticals, Inc. | 232.12 Million USD | -127.637% |
| Kala Pharmaceuticals, Inc. | 39.15 Million USD | -1249.577% |
| RedHill Biopharma Ltd. | -9.56 Million USD | 5626.619% |
| Organogenesis Holdings Inc. | 314.13 Million USD | -68.208% |
| Guardion Health Sciences, Inc. | 9.73 Million USD | -5330.161% |
| Cumberland Pharmaceuticals Inc. | 43.04 Million USD | -1127.679% |
| Radius Health, Inc. | 265.92 Million USD | -98.7% |
| Universe Pharmaceuticals INC | 13.84 Million USD | -3717.393% |
| ProPhase Labs, Inc. | 37.85 Million USD | -1295.963% |
| Phibro Animal Health Corporation | 260.29 Million USD | -102.998% |
| Procaps Group S.A. | 187.24 Million USD | -182.197% |
| Alvotech | 285.43 Million USD | -85.119% |
| TherapeuticsMD, Inc. | 9.82 Million USD | -5278.117% |
| Viatris Inc. | 5.96 Billion USD | 91.143% |
| Rockwell Medical, Inc. | 15.37 Million USD | -3336.972% |
| Aytu BioPharma, Inc. | 59.84 Million USD | -783.021% |
| SIGA Technologies, Inc. | 22.04 Million USD | -2297.13% |
| Tilray Brands, Inc. | 251.35 Million USD | -110.219% |
| Lifecore Biomedical, Inc. | 49.03 Million USD | -977.532% |
| Shineco, Inc. | 17.94 Million USD | -2844.054% |
| PetIQ, Inc. | 192.72 Million USD | -174.173% |
| Regencell Bioscience Holdings Limited | 3.99 Million USD | -13139.332% |
| Incannex Healthcare Limited | 30.05 Million USD | -1658.227% |
| Neurocrine Biosciences, Inc. | 1.59 Billion USD | 66.903% |
| Alimera Sciences, Inc. | 62.64 Million USD | -743.537% |
| Silver Spike Investment Corp. | 762.49 Thousand USD | -69199.088% |
| Assertio Holdings, Inc. | 368.58 Million USD | -43.359% |
| Shuttle Pharmaceuticals Holdings, Inc. | 5.88 Million USD | -8877.888% |
| Petros Pharmaceuticals, Inc. | 17.8 Million USD | -2867.117% |
| Clever Leaves Holdings Inc. | 21.16 Million USD | -2396.103% |
| Cyclo Therapeutics, Inc. | 21.04 Million USD | -2411.157% |
| Avadel Pharmaceuticals plc | 164.96 Million USD | -220.308% |
| Hempacco Co., Inc. | 7.59 Million USD | -6855.882% |
| Talphera, Inc. | 11.99 Million USD | -4305.536% |
| Alvotech | 285.43 Million USD | -85.119% |
| Eagle Pharmaceuticals, Inc. | 140.71 Million USD | -275.513% |
| Lantheus Holdings, Inc. | 344.9 Million USD | -53.203% |
| Currenc Group, Inc. | 24 Million USD | -2101.475% |
| Kamada Ltd. | 45.42 Million USD | -1063.21% |
| Indivior PLC | 911 Million USD | 41.998% |
| Evoke Pharma, Inc. | 12.4 Million USD | -4157.979% |
| Flora Growth Corp. | 10.57 Million USD | -4894.801% |
| Cyclo Therapeutics, Inc. | 21.04 Million USD | -2411.157% |
| Evolus, Inc. | 189.75 Million USD | -178.458% |
| HUTCHMED (China) Limited | 436.23 Million USD | -21.128% |
| Amphastar Pharmaceuticals, Inc. | 154.13 Million USD | -242.819% |
| Akanda Corp. | 3.48 Million USD | -15068.617% |